Eli Lilly settles insulin pricing lawsuit for $13.5M, monthly out-of-pocket commitment
Eli Lilly will pay $13.5 million and continue to cap out-of-pocket insulin costs at $35 per month for the next four years in what plaintiffs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
